2002 – 4th CRNI COURSE | Bergamo (Italy) | 20-23 March
Immunosoppressione non-selettiva
I Day
Non antigen specific immunosuppression
- Immunoregulatory effects of hormones (L. Matera)
- Immunisuppression using cytotoxic drugs:mechanisms of action (F. Valtorta)
- Bone marrow transplantation in autoimmunity (R. Saccardi)
II Day
Cytokine and chemokines: tools for immunotherapie
- Cytokines: mechanisms of action and immunological profile (M. Colombo)
- Chemokines: role in inflammation (P. Panina)
- Immunological mechansims of interferons (L. Rogge)
- Regulatory cells in innate immunity: possible drugs or possible therapeutic targets (P. Della Bona)
III Day
- Anti-cytokine antibodies: drug resistance or drug modulation? (A. Vincent)
- Pharmacological block of lymphocyte trafficking across the BBB: adhesion molecules and MMPs (G. Constantin)
- IFN b in MS: present use and future applications (V. Martinelli)
Antigen-specific immunotherapies
- The present and the future of the trimolecular complex (G. Casorati)
- Immunological basis of antigen-specific therapies (V. Barnaba)
- Antigen-specific therapies in CNS diseases; possible immunological targets (G. Ristori/M. Salvetti)
- Immune therapy in dysimmune neuropathies: present and future targets (E. Nobile-Orazio/M. Carpo).
IV Day
- Co-stimulatory molecules as possible new therapeutic target (L. Adorini)
- Altered peptide ligands and copaxone; preliminary experience in MS (G. Comi)
- Antigens and specific therapeutic targets in paraneoplastic diseases (B. Giometto)
- TNF a inhibitors as immunsuppressant drugs (P. Rieckman)